Evaluation of ethnoracial differences in self‐ and study partner‐reported subjective cognitive decline in the A4 Study screen data

Subjective cognitive decline (SCD) may represent an early clinical manifestation of Alzheimer’s disease (AD) pathology. There is evidence of an association between amyloid deposition and SCD. Given disparities in risk of AD and cognitive impairment across ethnoracial groups, there is need to evaluate SCD, cognition, and markers of AD across diverse samples, as well as study partners as reporters of SCD.